Table 4.
4.1B/DAL-1 LOH in tumors
| Tumor type | Number of cases/cell lines | Number of cases/cell lines with 4.1B/DAL-1 LOH (%) | References |
|---|---|---|---|
| Lung cancer | |||
| Primary NSCLC tumors | 100 | 39 (39) | [85] |
| Adenocarcinoma | 66 | 26 (39) | |
| Squamous cell carcinoma | 25 | 8 (32) | |
| Large cell carcinoma | 7 | 3 (43) | |
| Adenosquamous cells Carcinoma | 2 | 2 (100) | |
| Pleural fluid NSCLC | 100 | 39 (39) | |
| Breast cancer | |||
| Breast cancer tissues | 43 | 27 (63) | [92] |
| Ductal carcinoma | 16 | 9 (56) | |
| Invasive ductal carcinoma | 21 | 14 (67) | |
| Metastatic disease | 6 | 4 (67) | |
| Renal clear cell carcinoma | |||
| RCC cell lines | 19 | 9 (47) | [34] |
| Primary RCCC | 54 | 4 (7.4) | |
| Sporadic meningioma | |||
| Sporadic meningioma | 62 | 12 (19) | [94] |
| Benign | 31 | 1 (3) | |
| Malignant | 5 | 3 (60) | |